Pharmacokinetic/Pharmacodynamic Target Attainment of Ceftazidime in Adult Patients on General Wards with Different Degrees of Renal Function: A Prospective Observational Bicenter Cohort Study.

Autor: Zieck SE; Department of Pharmacy and Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Department of Hospital Pharmacy, Division of Clinical Pharmacology, Noordwest Ziekenhuisgroep, Location Alkmaar, Wilhelminalaan 12, 1815 JF Alkmaar, The Netherlands., de Vroom SL; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands., Mulder FP; Department of Hospital Pharmacy, Division of Clinical Pharmacology, Noordwest Ziekenhuisgroep, Location Alkmaar, Wilhelminalaan 12, 1815 JF Alkmaar, The Netherlands., van Twillert G; Department of Internal Medicine, Division of Infectious Diseases, Noordwest Ziekenhuisgroep, Location Alkmaar, Wilhelminalaan 12, 1815 JF Alkmaar, The Netherlands., Mathôt RAA; Department of Pharmacy and Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands., Geerlings SE; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands., van Hest RM; Department of Pharmacy and Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Department of Hospital Pharmacy, Division of Clinical Pharmacology, Noordwest Ziekenhuisgroep, Location Alkmaar, Wilhelminalaan 12, 1815 JF Alkmaar, The Netherlands.

Publikováno v: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2023 Feb 25; Vol. 12 (3). Date of Electronic Publication: 2023 Feb 25.

Asthma, bones and corticosteroids: Are inhaled corticosteroids associated with fractures in children with asthma?

Autor: Zieck SE; Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia., George J; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia., Blakeley BA; Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia., Welsh L; Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.; Royal Children's Hospital, Melbourne, Victoria, Australia., James S; School of Information Technology, Deakin University, Melbourne, Victoria, Australia., Ranganathan S; Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.; Royal Children's Hospital, Melbourne, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia., Simm P; Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.; Royal Children's Hospital, Melbourne, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia., Lim A; Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.

Publikováno v: Journal of paediatrics and child health [J Paediatr Child Health] 2017 Aug; Vol. 53 (8), pp. 771-777. Date of Electronic Publication: 2017 Jun 01.

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients.

Autor: Barbier, François^1,2 (AUTHOR) francois.barbier@chr-orleans.fr, Hraiech, Sami³ (AUTHOR), Kernéis, Solen⁴ (AUTHOR), Veluppillai, Nathanaël⁴ (AUTHOR), Pajot, Olivier⁵ (AUTHOR), Poissy, Julien⁶ (AUTHOR), Roux, Damien^2,7 (AUTHOR), Zahar, Jean-Ralph^2,8 (AUTHOR)

Publikováno v: Annals of Intensive Care. 7/18/2023, Vol. 13 Issue 1, p1-20. 20p.

Importance of antimicrobial stewardship in solid organ transplant recipients: An ESCMID perspective.

Autor: Ioannou, Petros¹ (AUTHOR), Karakonstantis, Stamatis¹ (AUTHOR), Schouten, Jeroen² (AUTHOR), Kostyanev, Tomislav^3,4 (AUTHOR), Charani, Esmita⁵ (AUTHOR), Vlahovic‐Palcevski, Vera⁶ (AUTHOR), Kofteridis, Diamantis P.¹ (AUTHOR) kofterid@uoc.gr

Publikováno v: Transplant Infectious Disease. Oct2022, Vol. 24 Issue 5, p1-6. 6p.

Clinical efficacy of renal dosing adjustments of ceftazidime–avibactam in patients affected by carbapenem‐resistant Gram‐negative infections: A systematic review and meta‐analysis of observational studies.

Autor: Gatti, Milo, Fornaro, Giacomo, Viale, Pierluigi, Pea, Federico, Giannella, Maddalena

Publikováno v: British Journal of Clinical Pharmacology; Feb2023, Vol. 89 Issue 2, p617-629, 13p